购物车
您的购物车当前为空
别名 PF 06946860
Ponsegromab (PF 06946860) 是一种具有选择性和有效性的人源化抗 GDF15 抗体抑制剂。 Ponsegromab 具有抗恶病质活性,通过与 GDF15 结合来阻止其与 GFRAL 结合,从而中断 GDF15/GFRAL 介导的信号传导。 Ponsegromab 具有潜在的抗癌活性,可用于治疗患有癌症厌食-恶病质综合征的癌症患者。
Ponsegromab (PF 06946860) 是一种具有选择性和有效性的人源化抗 GDF15 抗体抑制剂。 Ponsegromab 具有抗恶病质活性,通过与 GDF15 结合来阻止其与 GFRAL 结合,从而中断 GDF15/GFRAL 介导的信号传导。 Ponsegromab 具有潜在的抗癌活性,可用于治疗患有癌症厌食-恶病质综合征的癌症患者。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,320 | 现货 | |
| 5 mg | ¥ 5,490 | 现货 | |
| 10 mg | ¥ 7,480 | 现货 | |
| 25 mg | ¥ 10,900 | 现货 |
| 产品描述 | Ponsegromab (PF 06946860) is a selective and effective humanized anti-GDF15 antibody inhibitor. Ponsegromab has anti-cachexic activity by binding to GDF15 to prevent its binding to GFRAL, thus disrupting GDF15/GFRAL mediated signaling. Ponsegromab has potential anticancer activity and can be used to treat cancer patients with cancer anorexia cachexia syndrome. |
| 靶点活性 | GDF15:0.1095 μg/mL (EC50), GDF15-GFRAL:0.5037 μg/mL |
| 别名 | PF 06946860 |
| 反应种属 | Human |
| 验证活性 | 1. Immobilized Human GDF-15 Protein (His & HSA) can bind Ponsegromab. The EC50 is 3.834 ng/mL. 2. Immobilized Mouse GDF-15 Protein (His) can bind Ponsegromab. The EC50 is 5.7 ng/mL. 3. The binding of Human GDF-15 Protein (HSA & His) to the extracellular domain of biotinylated Human GFRAL Protein (Fc) can be blocked by Ponsegromab. ![]() ![]() ![]() |
| 应用 | ELISA FCM Functional assay |
| 抗体种类 | Monoclonal |
| 内毒素 | < 1 EU/mg as determined by the LAL method |
| 同型 | Human IgG1 kappa |
| 推荐同型对照 |
| 偶联 | Unconjugated |
| 基因ID | |
| Uniprot ID | |
| 靶点 | GDF15/MIC1 |
| 分子量 | 146.08 kDa |
| CAS No. | 2368950-15-4 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
对于不同动物的给药剂量换算,您也可以参考 更多